Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery

British Journal of Pharmacology

Volumn 121, Issue 2, 1997, Pages 253-263

  Devadason, Peter S S ^a   Henry, Peter J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Endothelin receptors; Endothelin 1; FR 139317; Kinetics; Radioligand binding; Renal artery; Sarafotoxin S6b; Smooth muscle contraction

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; RADIOLIGAND; SARAFOTOXIN S6B;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; KINETICS; LIGAND BINDING; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; VASCULAR ENDOTHELIUM;

EID: 0030941501     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701126     Document Type: Article

References (39)

1. BATTISTINI, B., O'DONNELL, L.J.D., WARNER, T.D., FOURNIER, A., FARTHING, M.J.G. & VANE, J.R. (1994). Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea-pig: evidence for an additional ET receptor subtype. Br. J. Pharmacol., 112, 1244-1250.
2. BAX, W.A., BOS, E. & SAXENA, P.R. (1993). Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur. J. Pharmacol., 239, 267-268.
3. BAX, W.A. & SAXENA, P.R. (1994). The current endothelin receptor classification: time for reconsideration. Trends Pharmacol. Sci., 15, 379-386.
4. 125I]-endothelin-1 binding sites in human umbilical artery. Eur. J. Pharmacol., 249, 299-305.
5. BUXTON, B.F., JONES, C.R., MOLENAAR, P. & SUMMERS, R.J. (1987). Characterization and autoradiographic localization of β-adrenoceptor subtypes in human cardiac tissues. Br. J. Pharmacol., 92, 299-310.
6. CLARK, K.L. & PIERRE, L. (1995). Characterization of endothelin receptors in rat renal artery in vitro. Br. J. Pharmacol., 114, 785-790.
7. CLOZEL, M., LOFFLER, B.M., BREU, V., HILFIGER, L., MAIRE, J.P. & BUTSCHA, B. (1993). Down-regulation of endothelin receptors by autocrine production of endothelin-1. Am. J. Physiol., 265, C188-C192.
8. DEVESLY, P., PHILLIPS, P.E., JOHNS, A., RUBANYI, G. & PARKER-BOTELHO, L.H. (1990). Receptor kinetics differ for endothelin-1 and endothelin-2 binding to Swiss 3T3 fibroblasts. Biochem. Biophys. Res. Copmmun., 192, 126-134.
9. EGLEZOS, A., CUCCHI, P., PATACCHINI, R., QUARTARA, L., MAGGI, C.A. & MIZRAHI, J. (1993). Differential effects of BQ-123 against endothelin-1 and endothelin-3 on the rat vas deferens: evidence for an atypical endothelin receptor. Br. J. Pharmacol., 109, 736-738.
10. GALRON, R., BDOLAH, A., KOCHVA, E., WOLLBERG, Z, KLOOG, Y. & SOKOLOVSKY, M. (1991). Kinetic and cross-linking studies indicate different receptors for endothelins and sarafotoxins in the ileum and cerebellum. FEBS Lett., 283, 11-14.
11. GODFRAIND, T. (1993). Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br. J. Pharmacol., 110, 1201-1205.
12. A) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction. Br. J. Pharmacol., 112, 749-756.
13. A endothelin receptors exhibit different sensitivities to BQ-123. Biochem. Biophys. Res. Commun., 224, 169-171.
14. HEMSEN, A., LARSSON, O. & LUNDBERG, J.M. (1991). Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues. Eur. J. Pharmacol., 208, 313-322.
15. HIRATA Y., YOSHIMI, H., YAKAICHI, S., YANAGISAWA, M. & MASAKI, T. (1988). Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett., 239, 13-17.
16. A) antagonist isolated from Streptomyces misakiensis. Biochem. Biophys. Res. Commun., 178, 132-137.
17. B) receptors. Life Sci., 51, PL47-PL52.
18. A receptor subtype. Eur. J. Pharmacol., 274, 1-6.
19. ISHIKAWA, H., HARANO, I., HARADA, Y., YOSHITOMI, T., ISHIKAWA, S. & KATORI, M. (1996). Pharmacological characterization of endothelin receptors in the rabbit iris sphincter muscle: suggestion for the presence of atypical receptors. Curr. Eye Res., 15, 73-78.
20. KARLSSON, M.O. & NEIL, A. (1988). Estimation of binding parameters by kinetic data analysis: differentiation between one and two binding sites. Eur. J. Pharmacol., 148, 115-121.
21. KENAKIN, T. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 165-222.
22. LE MONNIER DE GOUVILLE, A.C., LIPPTON, H., COHEN, G., CAVERO, I. & HYMAN, A. (1990). Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration. J. Pharmacol. Exp. Ther., 254, 1024-1028.
23. MAGUIRE, J.J., KUC, R.E., ROUS, B.A. & DAVENPORT, A.P. (1996). Failure of BQ-123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments. Br. J. Pharmacol., 118, 335-342.
24. MCPHERSON, G.A. (1985). Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J. Pharmacol. Methods, 14, 213-228.
25. MEAD, R., CURNOW, R.N. & HASTED, A.M. (1993). Statistical Methods in Agriculture and Experimental Biology, pp. 213-232. London: Chapman & Hall.
26. RESINK, T.J., SCOTT-BURDEN, T., BOULANGER, C., WEBER, E. & BUHLER, F.R. (1990). Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance. Mol. Pharmacol., 38, 244-252.
27. RIEZEBOS, J., WATTS, I.S. & VALLANCE, P.J.T. (1994). Endothelin receptors mediating functional responses in human small arteries and veins. Br. J. Pharmacol., 111, 609-615.
28. SALOM, J.B., TORREGROSA, G., BARBERA, M.D., JOVER, T. & ALBORCH, E. (1993). Endothelin receptors mediating contraction in goat cerebral arteries. Br. J. Pharmacol., 109, 826-830.
29. B receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Hypertension, 25, 501-506.
30. SCHOEFFTER, P. & RANDRIANTSOA, A (1993). Differences between endothelin receptors mediating contraction of guinea-pig aorta and pig coronary artery. Eur. J. Pharmacol., 249, 199-206.
31. A receptor antagonist. J. Pharmacol. Exp. Ther., 264, 1040-1046.
32. SOKOLOVSKY, M. (1995). Endothelin receptor subtypes and their role in transmembrane signalling mechanisms. Pharmacol. Ther., 68, 435-471.
33. B receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol., 107, 858-860.
34. A receptors. Eur. J. Pharmacol., 245, 229-232.
35. 125I]-endothelin binding data. Life Sci., 51, 1869-1876.
36. B receptors mediate vascular smooth muscle contraction. J. Cardiovasc. Pharmacol., 22 (Suppl 8), S144-S148.
37. A receptor agonists and antagonists. J. Cardiovasc. Pharmacol., 26, S380-S384.
38. WU-WONG, J.R., CHIOU, W.J., HUANG, Z., VIDAL, M.J. & OPGENORTH, T.J. (1994a). Endothelin receptors in human smooth muscle cells: antagonist potency differs on agonist-evoked responses. Am. J. Physiol., 267, C1185-C1195.
39. WU-WONG, J.R., CHIOU, W.J., NAUGLES, K.E. JR. & OPGENORTH, T.J. (1994b). Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist. Life Sci., 54, 1727-1734.